For many years, obesity was treated as a simple matter of willpower — eat less, move more. But as science evolved, we learned that obesity is a chronic, relapsing, and multifactorial disease. It is influenced by genetics, metabolism, hormones, environment, and psychological factors. That’s why modern medicine approaches obesity in the same structured way we approach conditions like hypertension or diabetes — through a treatment algorithm.
What Is the Obesity Treatment Algorithm?
The Obesity Treatment Algorithm is a guide developed by experts to help doctors choose the best treatment path for each patient, depending on their Body Mass Index (BMI), comorbidities, and previous response to treatments (Bays et al., 2021; Markovic et al., 2022).
This step-by-step approach ensures that every patient receives personalized, evidence-based care — not a one-size-fits-all recommendation.
(Adapted from Aronne, 2002; Markovic et al., 2022; Bays et al., 2021)
The Classic Algorithm (Before the “Medication Boom”)
Traditionally, the treatment of obesity followed a progressive structure like this:
| Stage | BMI Range | Recommended Treatment | Notes |
|---|---|---|---|
| 1. Lifestyle intervention | BMI ≥ 25 | Nutrition, physical activity, and behavioral therapy | Foundation for all patients |
| 2. Pharmacotherapy | BMI ≥ 30 or ≥ 27 with comorbidities | FDA-approved weight-loss medications | Added if lifestyle changes alone aren’t enough |
| 3. Bariatric (Metabolic) Surgery | BMI ≥ 40 or ≥ 35 with comorbidities | Procedures such as Gastric Sleeve or Gastric Bypass | Most effective and durable option for long-term weight loss |
(Adapted from Aronne, 2002; Markovic et al., 2022; Bays et al., 2021)
The New Reality: How GLP-1 and New Weight Loss Medications Changed the Landscape
In recent years, GLP-1 receptor agonists (such as semaglutide and tirzepatide) have transformed the conversation around obesity treatment. These medications can result in 15–20% total body weight loss, approaching the outcomes seen in some bariatric procedures.
However, as a bariatric surgeon, I remind patients that while these medications are promising, they are not a cure. The algorithm has evolved to integrate these new tools, not replace existing ones.
Here’s how the modernized algorithm looks today:
| Stage | BMI Range | Recommended Treatment | Comments |
|---|---|---|---|
| 1. Lifestyle and behavioral therapy | BMI ≥ 25 | Nutrition counseling, exercise, sleep, stress management | Always first-line treatment |
| 2. Pharmacotherapy (GLP-1, GIP/GLP-1) | BMI ≥ 30 or ≥ 27 with comorbidities | Used earlier and more broadly now | Often combined with lifestyle changes |
| 3. Bariatric Surgery | BMI ≥ 40 or ≥ 35 with comorbidities | Still the gold standard for long-term, sustained weight loss | Especially when metabolic diseases are involved |
| 4. Combination or Sequential Therapy | Variable | Medication + surgery or surgery + medication | Increasingly common in modern practice |
(Adapted from Salminen et al., 2024; Heidelbaugh, 2025; Bays et al., 2021)
Why This Shift Matters
The inclusion of these medications represents a more compassionate and realistic understanding of obesity. Many patients who previously felt “stuck” between lifestyle programs and surgery now have an intermediate option.
However, we also see many patients who:
-
Lose weight initially on medications but regain it after stopping
-
Experience side effects or plateaus
-
Or realize that their metabolic and hormonal imbalances still need surgical intervention
That’s why the obesity treatment algorithm is best viewed as a continuum — not a ladder you climb once, but a path you move through depending on your response and goals.
My Advice to Patients
Every patient deserves a personalized approach. Whether you’re considering medical therapy, surgery, or both, your treatment should be guided by an experienced team who understands how all these tools fit together.
At Do It Bariatrics, we use this integrated approach every day — combining modern science, nutrition, and compassionate care to help patients achieve long-term success.
📚 References (APA Format)
-
Aronne, L. J. (2002). Classification of obesity and assessment of obesity‐related health risks. Obesity Research, 10(S12), 105S–115S.
-
Bays, H. E., McCarthy, W., Christensen, S., Tondt, J., Karjoo, S., & Davisson, L. (2021, December). Obesity algorithm eBook, presented by the Obesity Medicine Association.
-
Heidelbaugh, J. J. (Ed.). (2025). Obesity Management: Obesity Management, E-Book (Vol. 15, No. 1). Elsevier Health Sciences.
-
Markovic, T. P., Proietto, J., Dixon, J. B., Rigas, G., Deed, G., Hamdorf, J. M., … & Colagiuri, S. (2022). The Australian Obesity Management Algorithm: A simple tool to guide the management of obesity in primary care. Obesity Research & Clinical Practice, 16(5), 353–363.
-
Salminen, P., Kow, L., Aminian, A., Kaplan, L. M., Nimeri, A., Prager, G., … & Shikora, S. (2024). IFSO consensus on definitions and clinical practice guidelines for obesity management—an international Delphi study. Obesity Surgery, 34(1), 30–42.
